Supernus Pharmaceuticals (SUPN) Change in Intangibles (2013 - 2021)

Supernus Pharmaceuticals (SUPN) has 9 years of Change in Intangibles data on file, last reported at $453000.0 in Q1 2021.

• Change in Intangibles for Q1 2021 came in at $453000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2021 was $594000.0 (down 55.93% YoY), and the FY2019 annual result was $1.3 million, up 66.75% from the prior year.
• Change in Intangibles advanced to $453000.0 in Q1 2021 per SUPN's latest filing, from $117000.0 in the prior quarter.
• Over five years, Change in Intangibles peaked at $5.8 million in Q2 2017 and troughed at $1000.0 in Q1 2019.
• A 5-year average of $1.1 million and a median of $343000.0 in 2018 frame the typical range for Change in Intangibles.
• On a YoY basis, Change in Intangibles climbed as much as 936.92% in 2019 and fell as far as 99.71% in 2019.
• A 5-year view of Change in Intangibles shows it stood at $1.0 million in 2017, then plunged by 87.3% to $130000.0 in 2018, then surged by 936.92% to $1.3 million in 2019, then tumbled by 91.32% to $117000.0 in 2020, then soared by 287.18% to $453000.0 in 2021.
• Business Quant data shows SUPN's Change in Intangibles at $453000.0 in Q1 2021, $117000.0 in Q3 2020, and $24000.0 in Q2 2020.